Report Detail
Global Gene Therapy in Cardiovascular Disorder Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4520766 |
- 14 March, 2023 |
- Global |
- 89 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Gene Therapy in Cardiovascular Disorder market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report is a detailed and comprehensive analysis for global Gene Therapy in Cardiovascular Disorder market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gene Therapy in Cardiovascular Disorder market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gene Therapy in Cardiovascular Disorder market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gene Therapy in Cardiovascular Disorder market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gene Therapy in Cardiovascular Disorder market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Therapy in Cardiovascular Disorder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Therapy in Cardiovascular Disorder market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Renovacor, Gene Biotherapeutics, AskBio, Human Stem Cells Institute and Novartis. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Gene Therapy in Cardiovascular Disorder market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Viral Gene Therapy
Non-viral Gene Therapy
Market segment by Application
Heart Disease
Vascular Disease
Market segment by players, this report covers
Renovacor
Gene Biotherapeutics
AskBio
Human Stem Cells Institute
Novartis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy in Cardiovascular Disorder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy in Cardiovascular Disorder, with revenue, gross margin and global market share of Gene Therapy in Cardiovascular Disorder from 2018 to 2023.
Chapter 3, the Gene Therapy in Cardiovascular Disorder competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Therapy in Cardiovascular Disorder market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy in Cardiovascular Disorder.
Chapter 13, to describe Gene Therapy in Cardiovascular Disorder research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Gene Therapy in Cardiovascular Disorder
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Gene Therapy in Cardiovascular Disorder by Type
- 1.3.1 Overview: Global Gene Therapy in Cardiovascular Disorder Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Gene Therapy in Cardiovascular Disorder Consumption Value Market Share by Type in 2022
- 1.3.3 Viral Gene Therapy
- 1.3.4 Non-viral Gene Therapy
- 1.4 Global Gene Therapy in Cardiovascular Disorder Market by Application
- 1.4.1 Overview: Global Gene Therapy in Cardiovascular Disorder Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Heart Disease
- 1.4.3 Vascular Disease
- 1.5 Global Gene Therapy in Cardiovascular Disorder Market Size & Forecast
- 1.6 Global Gene Therapy in Cardiovascular Disorder Market Size and Forecast by Region
- 1.6.1 Global Gene Therapy in Cardiovascular Disorder Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Gene Therapy in Cardiovascular Disorder Market Size by Region, (2018-2029)
- 1.6.3 North America Gene Therapy in Cardiovascular Disorder Market Size and Prospect (2018-2029)
- 1.6.4 Europe Gene Therapy in Cardiovascular Disorder Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size and Prospect (2018-2029)
- 1.6.6 South America Gene Therapy in Cardiovascular Disorder Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Gene Therapy in Cardiovascular Disorder Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Renovacor
- 2.1.1 Renovacor Details
- 2.1.2 Renovacor Major Business
- 2.1.3 Renovacor Gene Therapy in Cardiovascular Disorder Product and Solutions
- 2.1.4 Renovacor Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Renovacor Recent Developments and Future Plans
- 2.2 Gene Biotherapeutics
- 2.2.1 Gene Biotherapeutics Details
- 2.2.2 Gene Biotherapeutics Major Business
- 2.2.3 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product and Solutions
- 2.2.4 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Gene Biotherapeutics Recent Developments and Future Plans
- 2.3 AskBio
- 2.3.1 AskBio Details
- 2.3.2 AskBio Major Business
- 2.3.3 AskBio Gene Therapy in Cardiovascular Disorder Product and Solutions
- 2.3.4 AskBio Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 AskBio Recent Developments and Future Plans
- 2.4 Human Stem Cells Institute
- 2.4.1 Human Stem Cells Institute Details
- 2.4.2 Human Stem Cells Institute Major Business
- 2.4.3 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product and Solutions
- 2.4.4 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Human Stem Cells Institute Recent Developments and Future Plans
- 2.5 Novartis
- 2.5.1 Novartis Details
- 2.5.2 Novartis Major Business
- 2.5.3 Novartis Gene Therapy in Cardiovascular Disorder Product and Solutions
- 2.5.4 Novartis Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Novartis Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Gene Therapy in Cardiovascular Disorder Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Gene Therapy in Cardiovascular Disorder by Company Revenue
- 3.2.2 Top 3 Gene Therapy in Cardiovascular Disorder Players Market Share in 2022
- 3.2.3 Top 6 Gene Therapy in Cardiovascular Disorder Players Market Share in 2022
- 3.3 Gene Therapy in Cardiovascular Disorder Market: Overall Company Footprint Analysis
- 3.3.1 Gene Therapy in Cardiovascular Disorder Market: Region Footprint
- 3.3.2 Gene Therapy in Cardiovascular Disorder Market: Company Product Type Footprint
- 3.3.3 Gene Therapy in Cardiovascular Disorder Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Gene Therapy in Cardiovascular Disorder Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Gene Therapy in Cardiovascular Disorder Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Gene Therapy in Cardiovascular Disorder Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Gene Therapy in Cardiovascular Disorder Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Gene Therapy in Cardiovascular Disorder Consumption Value by Type (2018-2029)
- 6.2 North America Gene Therapy in Cardiovascular Disorder Consumption Value by Application (2018-2029)
- 6.3 North America Gene Therapy in Cardiovascular Disorder Market Size by Country
- 6.3.1 North America Gene Therapy in Cardiovascular Disorder Consumption Value by Country (2018-2029)
- 6.3.2 United States Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 6.3.3 Canada Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Gene Therapy in Cardiovascular Disorder Consumption Value by Type (2018-2029)
- 7.2 Europe Gene Therapy in Cardiovascular Disorder Consumption Value by Application (2018-2029)
- 7.3 Europe Gene Therapy in Cardiovascular Disorder Market Size by Country
- 7.3.1 Europe Gene Therapy in Cardiovascular Disorder Consumption Value by Country (2018-2029)
- 7.3.2 Germany Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 7.3.3 France Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 7.3.5 Russia Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 7.3.6 Italy Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Gene Therapy in Cardiovascular Disorder Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Gene Therapy in Cardiovascular Disorder Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region
- 8.3.1 Asia-Pacific Gene Therapy in Cardiovascular Disorder Consumption Value by Region (2018-2029)
- 8.3.2 China Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 8.3.3 Japan Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 8.3.5 India Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 8.3.7 Australia Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Gene Therapy in Cardiovascular Disorder Consumption Value by Type (2018-2029)
- 9.2 South America Gene Therapy in Cardiovascular Disorder Consumption Value by Application (2018-2029)
- 9.3 South America Gene Therapy in Cardiovascular Disorder Market Size by Country
- 9.3.1 South America Gene Therapy in Cardiovascular Disorder Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Gene Therapy in Cardiovascular Disorder Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Gene Therapy in Cardiovascular Disorder Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country
- 10.3.1 Middle East & Africa Gene Therapy in Cardiovascular Disorder Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
- 10.3.4 UAE Gene Therapy in Cardiovascular Disorder Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Gene Therapy in Cardiovascular Disorder Market Drivers
- 11.2 Gene Therapy in Cardiovascular Disorder Market Restraints
- 11.3 Gene Therapy in Cardiovascular Disorder Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Gene Therapy in Cardiovascular Disorder Industry Chain
- 12.2 Gene Therapy in Cardiovascular Disorder Upstream Analysis
- 12.3 Gene Therapy in Cardiovascular Disorder Midstream Analysis
- 12.4 Gene Therapy in Cardiovascular Disorder Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Gene Therapy in Cardiovascular Disorder. Industry analysis & Market Report on Gene Therapy in Cardiovascular Disorder is a syndicated market report, published as Global Gene Therapy in Cardiovascular Disorder Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Gene Therapy in Cardiovascular Disorder market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
